Top Menu HELP dot CONTACT US dot LOGIN  

www.leo-sarath.com // Dedicated to Leadership in Dermatology
 
Dedicated to Leadership in Dermatology

Challenge | Psoriasis

Our goal is to provide patients suffering from skin diseases such as psoriasis with the very best solutions.

As a professional dermatology company, we see the challenges faced by psoriasis patients as our challenges.

Everything we do stems from listening to and understanding the everyday hurdles faced by psoriasis patients. Patients for whom healthy, comfortable-to-wear skin can no longer be taken for granted.


Quality of life

We have learned that only half of patients suffering from psoriasis today receive satisfactory treatment. We want to change that.

We want to increase the awareness of effective treatment in order to bring improved quality of life to many more patients.

We want to reduce physical and social discomfort – studies have shown that psoriasis affects the quality of life of patients and their relatives in many negative ways.

Moreover, we want to continue to expand our psoriasis business considerably, because our broad portfolio of safe and efficacious drugs represents the best within the topical treatment of psoriasis.

It is the strategic goal of LEO Pharma to be the global leader within anti-psoriasis therapies based on innovative and efficacious products and associated services.

LEO Pharma has open eyes and listening ears in more than 40 countries in the world. We have more than 1,000 dedicated Sales & Marketing people, of whom approx 800 enthusiastically work in the field selling our comprehensive range of products. They are marketed in 90 countries.




For additional information or comments please contact: 

Mrs. Evie Smyrnopoulou 
IT/Web Coordinator 

evie.smyrnopoulou@leo-pharma.com 

 
 

Login to Restricted Web Area
Email:
Password:
 
 
News
12-11-2009 - LEO Pharma Completes Peplin Acquisition
Danish LEO Pharma has gained additional ground in the US after finalising the agreement to acquire Australian-US Peplin, Inc. Read More

1-10-2009 - LEO Pharma acquires own portfolio in the US
LEO Pharma A/S, a world leader in treatment of dermatological diseases, has re-acquired the US-rights to the company’s psoriasis portfolio and dermatology pipeline from the previous partner in the US, Warner Chilcott. The transaction sum is set at... Read More

1-1-2009 - LEARN MORE ABOUT...
Patient Educational Material Read More

SITEMAP Disclaimer Privacy Policy
LEO Pharmaceutical Products Sarath LTD . 5, Himaras street . 3rd floor . GR-151 25 Marousi . Athens . Greece. Tel: +30 210 9954545 . Fax: +30 210 9940565 .
E-mail: leo.roa@leo-pharma.com